Nicolas Grundmann is the Co-founder and CEO of Ember Health, which provides IV ketamine treatments for depression. As a board-certified emergency medicine physician, he launched Ember Health to create more effective, patient-centered treatment options. Nicolas is also a faculty member at the American Society of Ketamine Physicians, Psychotherapists and Practitioners, and is the Co-founder of Chenla Children’s Healthcare, which improves pediatric care in Cambodia.

In this episode…

Mental health treatment is evolving as clinicians search for options that outperform traditional approaches. From data-driven care to treating trauma, anxiety, and depression together, how can clinicians create evidence-based ketamine treatments?

According to emergency medicine physician Nicolas Grundmann, effective ketamine treatment starts with rigorous evidence, longitudinal data, and close care coordination. He emphasizes symptom-driven dosing, regular measurement using validated tools, and proactive follow-up to catch relapses early. Clinicians should also integrate outside therapists, help patients relearn emotional regulation after depression lifts, and avoid one-size-fits-all models.

In this episode of Living Medicine, Dr. Sandy Newes talks with Nicolas Grundmann, Co-founder and CEO of Ember Health, about evidence-based ketamine treatment for depression. Nicolas talks about using real-world data to guide care, treating depression with comorbid PTSD and anxiety, and whether to include therapy during ketamine sessions.